WILLIAM PEACOCK to Cost-Benefit Analysis
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Cost-Benefit Analysis.
Connection Strength
0.179
-
Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin. Intern Emerg Med. 2017 Apr; 12(3):311-318.
Score: 0.103
-
Clinical and economic benefits of using AUDICOR S3 detection for diagnosis and treatment of acute decompensated heart failure. Congest Heart Fail. 2006 Jul-Aug; 12 Suppl 1:32-6.
Score: 0.050
-
Necessity of hospitalization and stress testing in low risk chest pain patients. Am J Emerg Med. 2017 Feb; 35(2):274-280.
Score: 0.026